Sharp Biomedical
PrivateLast Round
Pre Seed
Oct 12, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Sharp Biomedical is a medical device company that develops streamlined toolsets and implants for spinal care to support outpatient pain clinics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sharp Biomedical Comparables
Compare Sharp Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Wenzel Spine, Inc. | 78% | |
| Spineology | 78% | |
| Spinal Simplicity | 78% |
Sharp Biomedical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 12, 2026 |
Sharp Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| gener8tor | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 12, 2026
Led by gener8tor
Sharp Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sharp Biomedical's valuation, stock price, and market status.
Is Sharp Biomedical a public or private company?
Sharp Biomedical is a private company.
What is the current stock price of Sharp Biomedical?
Sharp Biomedical is a private company, so its shares have no public market price. Caplight tracks Sharp Biomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sharp Biomedical worth (valuation)?
Valuation information for Sharp Biomedical is not publicly available.
Can I buy Sharp Biomedical stock?
Sharp Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sharp Biomedical's last funding round?
Sharp Biomedical's most recent funding round was Pre Seed on October 12, 2026.
Who are the main investors in Sharp Biomedical?
Key investors in Sharp Biomedical include gener8tor.
Will Sharp Biomedical IPO soon?
No public IPO plans have been announced for Sharp Biomedical.
How can I track Sharp Biomedical secondary market activity?
Caplight tracks bids, offers, and trades in Sharp Biomedical's shares on secondary markets.